214 related articles for article (PubMed ID: 19080477)
1. [The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma].
Li J; Zhao Y; Luo SK; Huang BH; Zhang GC; Peng AH; Zheng D; Su C; Xu DR; Tong XZ; Gu JL; Ding Y
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2140-3. PubMed ID: 19080477
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: the National University Hospital (NUH) experience.
Lim HL; Teo CP; Wong K; Kuperan P; Suri R; Tan YO; Kueh YK
Singapore Med J; 1994 Aug; 35(4):371-3. PubMed ID: 7899894
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma in the region of Bursa, Turkey: a retrospective analysis.
Ozkalemkaş F; Ali R; Tunali A; Ozkocaman V; Ozyardimci C; Ozçelik T
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):267-70. PubMed ID: 9216819
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis delay of multiple myeloma: report of 22 cases in an internal medicine department of Dakar].
Pouye A; Ka MM; Dia D; Guéye N; Diallo S; Ndongo S; Lèye AN; Diop T
Dakar Med; 2004; 49(2):132-5. PubMed ID: 15786624
[TBL] [Abstract][Full Text] [Related]
6. Early response to therapy and survival in multiple myeloma.
Schaar CG; Kluin-Nelemans JC; le Cessie S; Franck PF; te Marvelde MC; Wijermans PW
Br J Haematol; 2004 Apr; 125(2):162-6. PubMed ID: 15059138
[TBL] [Abstract][Full Text] [Related]
7. [On the diagnosis of multiple myeloma an analysis of 2,547 domestic cases].
Li S; Li H; Zhao X
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):43-6. PubMed ID: 7656787
[TBL] [Abstract][Full Text] [Related]
8. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients.
Clavio M; Casciaro S; Gatti AM; Spriano M; Bonanni F; Poggi A; Vallebella E; Pietrasanta D; Prencipe E; Goretti R; Vimercati R; Rossi E; Masoudi B; Ghio R; Boccaccio P; Ricciardi S; Damasio E; Gobbi M
Haematologica; 1996; 81(3):238-44. PubMed ID: 8767529
[TBL] [Abstract][Full Text] [Related]
10. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
Pruzanski W; Rother I
Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
[TBL] [Abstract][Full Text] [Related]
11. Biochemical abnormalities in multiple myeloma.
Choo-Kang E; Campbell M
West Indian Med J; 1991 Dec; 40(4):170-2. PubMed ID: 1785196
[TBL] [Abstract][Full Text] [Related]
12. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
[TBL] [Abstract][Full Text] [Related]
13. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
Chepovetsky J; Chari A; Jagannath S; Ramanthan L
Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical studies in multiple myeloma.
Thakar YS; Chande C; Pande S; Dhanvijay AG; Shrikhande AV; Saoji AM
Indian J Cancer; 1997 Dec; 34(4):151-8. PubMed ID: 9715537
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
Hulin C; Facon T; Rodon P; Pegourie B; Benboubker L; Doyen C; Dib M; Guillerm G; Salles B; Eschard JP; Lenain P; Casassus P; Azaïs I; Decaux O; Garderet L; Mathiot C; Fontan J; Lafon I; Virion JM; Moreau P
J Clin Oncol; 2009 Aug; 27(22):3664-70. PubMed ID: 19451428
[TBL] [Abstract][Full Text] [Related]
16. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
17. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J
Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753
[TBL] [Abstract][Full Text] [Related]
18. Comparison among immunologically different subtypes of 595 untreated multiple myeloma patients in northern China.
Zhang L; Qi JY; Qi PJ; Wang YF; Zou DH; Yao HJ; An G; Yi SH; Li Q; Qiu LG
Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):197-204. PubMed ID: 20511165
[TBL] [Abstract][Full Text] [Related]
19. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: diagnosis and treatment.
Nau KC; Lewis WD
Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]